Chemiluminescence Immunoassay Analyzers Market Size Worth USD 9.7 Billion in 2032 | Emergen Research
December 18, 2023 06:54 ET
|
Emergen Research
Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) -- The global Chemiluminescence Immunoassay (CLIA) analyzers market size was USD 5.42 Billion in 2022 and is expected to register rapid revenue CAGR of 6.0%...
Bovine Diagnostics Market worth $2 Billion by 2030 - Exclusive Report by The Insight Partners
September 13, 2023 09:34 ET
|
The Insight Partners
Pune, India, Sept. 13, 2023 (GLOBE NEWSWIRE) -- Bovine tuberculosis (bTB) is a chronic infectious disease that primarily affects cattle, and is later transmitted to other animals and humans. The...
Clinical Immunoanalyzer Market Advancing Towards USD 7,045.57 Million By 2030
August 22, 2023 06:00 ET
|
CONSEGIC BUSINESS INTELLIGENCE PRIVATE LIMITED
New York, Aug. 22, 2023 (GLOBE NEWSWIRE) -- The global Clinical Immunoanalyzer Market is expected to witness significant growth at a remarkable CAGR of 5.0% during the forecast period of...
Global Chemiluminescence Immunoassay Analyzer Market Size is Anticipated to Acquire USD 8.01 Billion by 2030 With a CAGR of 5.44%
August 04, 2023 14:41 ET
|
Zion Market Research
SAN FRANCISCO, U.S., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Chemiluminescence Immunoassay Analyzer Market By Product (Instruments,...
$34.48Bn Growth for Immunodiagnostics Market Share to Hit 7.6% CAGR with Chemiluminescence Immunoassays (CLIA) Segment Driving Growth During 2022-2030 | The Insight Partners
July 20, 2023 10:31 ET
|
The Insight Partners
Pune, India, July 20, 2023 (GLOBE NEWSWIRE) -- According to Recently Published Report by The Insight Partners, “Immunodiagnostics Market Size Report and Forecast to 2030 - COVID-19 Impact and Global...
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
January 25, 2023 08:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
January 20, 2023 16:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
ProPhase Labs to Present at The ThinkEquity Conference
October 18, 2022 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 18, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be...
Nebula Genomics Strengthens Advisory Board with Appointment of Russ Altman, M.D., Ph.D.
October 17, 2022 08:00 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Oct. 17, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, today announced that its wholly...
Chemiluminescence Immunoassay Market Size is projected to reach USD 12.73 Billion by 2030, growing at a CAGR of 7.5%: Straits Research
September 07, 2022 12:50 ET
|
Straits Research
New York, United States, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Chemiluminescence immunoassay (CLIA) is an immunological technique used for the detection and monitoring of chronic disorders. The...